BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Del Hoyo J, Millán M, Garrido-Marín A, Aguas M. Are we ready for telemonitoring inflammatory bowel disease? A review of advances, enablers, and barriers. World J Gastroenterol 2023; 29(7): 1139-1156 [PMID: 36926667 DOI: 10.3748/wjg.v29.i7.1139]
URL: https://www.wjgnet.com/1007-9327/full/v29/i7/1139.htm
Number Citing Articles
1
Anke Erdmann, Florian Schrinner, Christoph Rehmann-Sutter, Andre Franke, Ursula Seidler, Stefan Schreiber, Claudia Bozzaro. Acceptability Criteria of Precision Medicine: Lessons From Patients’ Experiences With the GUIDE-IBD Trial Regarding the Use of Mobile Health TechnologyCrohn's & Colitis 360 2023; 5(4) doi: 10.1093/crocol/otad068
2
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
3
Antonietta Gerarda Gravina, Raffaele Pellegrino, Tommaso Durante, Giovanna Palladino, Rossella D'Onofrio, Simone Mammone, Giusi Arboretto, Salvatore Auletta, Giuseppe Imperio, Andrea Ventura, Mario Romeo, Alessandro Federico. Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future?World Journal of Methodology 2023; 13(4): 194-209 doi: 10.5662/wjm.v13.i4.194
4
Ferdinando D’Amico, Ernesto Fasulo, Vipul Jairath, Kristine Paridaens, Laurent Peyrin-Biroulet, Silvio Danese. Management and treatment optimization of patients with mild to moderate ulcerative colitisExpert Review of Clinical Immunology 2024; 20(3): 277 doi: 10.1080/1744666X.2023.2292768
5
Massimo Claudio Fantini, Erica Loddo, Amalia Di Petrillo, Sara Onali. Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative reviewDigestive and Liver Disease 2024; 56(1): 1 doi: 10.1016/j.dld.2023.05.035